Asklepios Biopharmaceutical Inc
Scientific Laboratories
Why pick this one
AskBio develops AAV gene therapies and has an active, recruiting clinical trial for late-onset Pompe disease.
Best for
- AAV gene therapy research and development
- Gene therapy clinical trial information
- Research collaborations in genetic medicine
- AAV manufacturing technology
- Investigational therapies for late-onset Pompe disease, Parkinson’s disease, or heart failure
Look elsewhere if
- Routine diagnostic laboratory testing
- General-purpose laboratory services
- Immediate treatment from an approved commercial therapy
- Emergency medical care
Specialties
- AAV gene therapy technology
- AAV gene therapy therapeutics
- AAV manufacturing technology
- Gene therapy clinical trials
- Genetic medicine research and development
What makes them different
- Focuses on adeno-associated virus (AAV) gene therapy technology and therapeutics
- Maintains an active, recruiting clinical trial for late-onset Pompe disease
- Has clinical programs involving congestive heart failure, Parkinson’s disease, multiple system atrophy, and LGMD2I/R9
- Operates or lists manufacturing facilities in San Sebastián, Spain, including TAAV and Viralgen facilities
- Is a wholly owned, independently operated subsidiary of Bayer AG
Distilled from this business's own website.
Contact & Location
- Address
- 45 N Chatham Pkwy, Chapel Hill, NC 27517-6040
- Website
- http://www.askbio.com
Services
- Gene therapy research and development
- Clinical trial programs
- AAV technology development
- Research collaboration
- Biomanufacturing and viral vector manufacturing